BB BIOTECH AG - 31 Dec 2024 SCHEDULE 13G/A Report for Black Diamond Therapeutics, Inc. Common Stock (BDTX)

Filing Manager: BB BIOTECH AG
Reporting Manager: BB Biotech AG
Security: Black Diamond Therapeutics, Inc. Common Stock
Symbol: BDTX
Shares outstanding: 56,409,530 shares
Disclosed Ownership: 8,517,839 shares
Ownership: 15%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 14:36:15 UTC
Date of event: 31 Dec 2024
Next filing: 21 Mar 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BB Biotech AG	15%	8,517,839	0	8,517,839	/s/ Martin Gubler	Martin Gubler/Signatory Authority
Biotech Growth N.V.	15%	8,517,839	0	8,517,839	/s/ Jan Bootsma	Jan Bootsma/Signatory Authority